Research Portfolio

Research > Research Portfolio

Stand Up To Cancer funds collaborative, scientifically rigorous, treatment-focused research to develop new therapies for people with cancer. We support research both on individual cancers and on the underlying mechanisms of cancer.

We do this by funding Team Science, which brings researchers together to work on multidisciplinary projects across universities, medical centers and companies. We also provide Grants to Individuals, which bring new scientists and their ideas into cancer research by funding high-risk, high-reward projects that may not receive support through traditional grant programs.

For the full Research Portfolio, click here.

TEAM SCIENCE

DREAM TEAMS

Stand Up To Cancer Dream Teams pursue cancer research projects that address critical problems in cancer prevention, diagnosis and treatment to deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, collaborative team of expert investigators and patient advocates. These teams, selected and guided by leaders in the field, take innovative ideas from concept to patient in order to see whether they have the potential to revolutionize cancer care and open whole new fields of investigation.

LEARN MORE

Multiple Accelerated Therapies
Up to 50 Researchers
Multiple Institutions
Stand Up To Cancer Oversight

Flagship projects that bring together multidisciplinary teams from different institutions to address critical problems in cancer prevention, diagnosis, and treatment.

Accelerated Therapies and Screening Tools
Multiple Researchers
Multiple Institutions
Stand Up To Cancer Oversight

Multi-institutional research projects that seek proof of principle for emerging questions in translational cancer research.

RESEARCH TEAMS

Stand Up To Cancer Research Grants fund cancer research projects that address critical problems in patient care and deliver near-term patient benefit through investigation by small, collaborative teams of expert investigators. These teams conduct proof of principle projects and spearhead work in new fields.

Learn More

CONVERGENCE

Convergence Grants bring together quantitative scientists and oncologists in integrated projects focused on cancer biology. Convergence Grants seek to accelerate cancer research and treatment for patients by bringing together scientists from diverse yet complementary disciplines (such as nanotechnology or new materials science).

LEARN MORE

Biomedical Researchers
Computational Scientists
Physicists and Mathematicians
Stand Up To Cancer Oversight

For “out there” questions that require a team with diverse expertise to answer.

Combination Therapies
Proof-of-Principle Clinical Trials
Stand Up To Cancer Oversight

Efficient, quick “signal finding” clinical trials of new therapeutic combinations.

SU2C CATALYST™

SU2C Catalyst™ uses funding and materials from the pharmaceutical, biotechnology, diagnostic, and medical device industries to rapidly explore new uses of potential compounds for cancer prevention, detection and treatment. Projects are required to be multi-investigator and multi-institutional.

LEARN MORE

NEW THERAPIES CHALLENGE RESEARCH TEAMS

New Therapies Challenge Research Teams, part of a focused effort to increase therapies to treat pancreatic cancer, support investigations of novel or repurposed treatments that have the potential to significantly impact pancreatic cancer patients in the near term. Successful research teams will be eligible to apply for additional funding for further clinical studies.

Learn More

Combination Therapies
Drug Compounds
Proof of Principle Clinical Trials
Stand Up To Cancer Oversight

Efficient, quick ‘signal-finding’ clinical trials for new treatments for pancreatic cancer.

ADDITIONAL TEAM AWARDS

We believe in big ideas. In addition to SU2C’s research portfolio, several other avenues of funding are available to researchers and scientists with a high potential to impact patient care. SU2C enables outside-the-box collaborations and supports the next generation of scientists who will shape the future of cancer research through unique awards including the Phillip A. Sharp Innovation in Collaboration Awards and the Laura Ziskin Prize.

The Phillip A. Sharp Innovation In Collaboration Awards

The hallmark of the Sharp Awards process is its quick ability to spark “aha” moments. Brief proposals are reviewed during the annual SU2C Summit by a committee of senior scientists and the awards are announced at that same meeting.

The Laura Ziskin Prize

This prize is named for SU2C Co-founder Laura Ziskin, legendary Hollywood producer, who co-founded SU2C and lived with breast cancer for seven years before she died in 2011. The grant is shared by two scientists at different institutions. Funds are used to collaborate on high-risk, high-reward breast cancer research.

The Jim Toth Sr. Breakthrough Lung Cancer Research Award

This award is named in honor of Jim Toth Sr., who passed away from lung cancer and is intended to provide funding for highly innovative, clinically focused cancer research.

Individual Awards

INNOVATIVE RESEARCH GRANTS

SU2C’s Innovative Research Grants (IRGs) support cutting-edge cancer research that would be deemed too high-risk to pursue through traditional channels. IRGs provide significant funding to early-career scientists with novel ideas that have a strong potential to impact patient care.

LEARN MORE

1 Researcher
Bold Idea
Stand Up To Cancer Oversight

Significant funding for early-career scientists for cutting-edge, novel projects that have a strong potential to impact patient care and might not receive funding through traditional channels.

ADDITIONAL INDIVIDUAL AWARDS

SU2C Peggy Prescott Early Career Scientist Award

The award provides $50,000 in research funding over a two-year term to a rising star in the colorectal cancer field. The fellowship honors Peggy Prescott, mother of Dallas Cowboys quarterback, Dax Prescott, who passed away from colorectal cancer in 2013.

Golden Arrow Award

The SU2C Golden Arrow Early Career Scientist Award is targeted at early career scientists, including postdoctoral fellows and clinical fellows, who are bringing new work to a current SU2C research project. This award provides $100,000 over one year.

Steve Golin Prize

The Steve Golin Fund accelerates research in Ewing sarcoma, a rare bone and soft tissue cancer predominantly found in children.

Emperor Science Awards

From 2016 through 2018, the Emperor Science Award program offered high school students from across the United States the opportunity to explore careers in cancer research through a mentored scientific research project. Through annual competitions, 300 students participated in the program and received a stipend and laptop computer. This education initiative was inspired by Ken Burns Presents CANCER: THE EMPEROR OF ALL MALADIES A Film by Barak Goodman, a three-part film on the history of cancer that aired on PBS in the spring of 2015.

Learn more about the Emperor Science Award.

STRATEGIC COLLABORATIONS

The power of collaboration and cooperation is at the heart of Stand Up To Cancer. SU2C works with like-minded organizations to jointly fund research projects with the aim of eliminating specific cancers. Our collaborators offer subject matter expertise on issues and concerns specific to their constituencies and patient populations. As we mobilize our scientific competencies, we work together to fulfill our shared goals and vision.

These leading cancer research organizations will inspire new collaborators; improve diagnosis of pancreatic cancer using big data; develop new treatments for pancreatic cancer; and support the next generation of pancreatic cancer investigators.

LEARN MORE

The SU2C Kate McGarrigle Fund is a new collaborative program from Stand Up To Cancer and the Kate McGarrigle Foundation that aims to provide music therapy resources to cancer patients with a passion for music, as well as much-needed funds for sarcoma research.

LEARN MORE